The efficacy of transcatheter aortic valve implantation (TAVI) in high surgical risk and
inoperable patients with severe aortic stenosis (AS) is rapidly gaining credibility with an ever …

OBJECTIVES The German Aortic Valve Registry (GARY) seeks to provide information on a
real-world, all-comers basis for patients undergoing aortic valve interventions. This registry …

Patients with severe aortic stenosis who are at high surgical risk or not considered to be
suitable candidates for surgical aortic valve replacement are increasingly being treated with …

Aims Transcatheter aortic valve implantation (TAVI) is an established treatment alternative to
surgical aortic valve replacement in high-risk and inoperable patients and outcomes among …

Background Conventional aortic valve replacement (AVR) remains the therapy of choice for
many patients with severe aortic valve disease. The unique German Aortic Valve Registry …

Transcatheter aortic valve replacement (TAVR) is entering its second decade. Three major
clinical challenges have emerged from the first decade of experience: vascular …

Transcatheter aortic valve replacement represents one of the most exciting medical
technical developments in recent years, offering a much-needed therapeutic alternative for …

Artificial heart valves, used to replace diseased human heart valves, are life-saving medical
devices. Currently, at the device development stage, new artificial valves are primarily …

BACKGROUND: Aneurysms-osteoarthritis syndrome (AOS), caused by SMAD3 mutations, is
a recently described autosomal dominant condition characterized by aneurysms throughout …

Transcatheter aortic valve replacement (TAVR) constitutes a relatively new treatment option
for the patients with severe symptomatic aortic stenosis. Evidence from registries and …